FZACX
Price
$44.99
Change
-$0.52 (-1.14%)
Updated
Jul 13 closing price
Net Assets
4.27B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

FZACX vs VFFSX

FZACX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
FZACX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZACX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. FZACX (4.27B). VFFSX pays higher dividends than FZACX: VFFSX (1.08) vs FZACX (0.42). FZACX was incepted earlier than VFFSX: FZACX (13 years) vs VFFSX (10 years). FZACX (0.44) is less costly to investors than VFFSX (0.01). FZACX is a more actively managed with annual turnover of: 85.00 vs. VFFSX (2.00). FZACX has a lower initial minimum investment than VFFSX: FZACX (0) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. FZACX (17.23). VFFSX return over 5 years is better than : 73.48 vs. FZACX (20.49).
FZACXVFFSXFZACX / VFFSX
Total Expense Ratio0.440.014,400%
Annual Report Gross Expense Ratio0.440.014,400%
Fund Existence13 years10 years-
Gain YTD13.46310.685126%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.27B1.67T0%
Annual Yield % from dividends0.421.0839%
Returns for 1 year17.2321.0782%
Returns for 3 years43.7168.4564%
Returns for 5 years20.4973.4828%
Returns for 10 years114.60251.2146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6